MAZZEO, SALVATORE
 Distribuzione geografica
Continente #
EU - Europa 1.649
AS - Asia 1.440
NA - Nord America 1.106
SA - Sud America 209
AF - Africa 37
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.451
Nazione #
US - Stati Uniti d'America 1.041
RU - Federazione Russa 817
SG - Singapore 573
IT - Italia 468
CN - Cina 463
BR - Brasile 168
HK - Hong Kong 152
VN - Vietnam 108
DE - Germania 68
FR - Francia 65
GB - Regno Unito 55
NL - Olanda 42
CA - Canada 37
BD - Bangladesh 34
IN - India 28
FI - Finlandia 24
AT - Austria 23
PL - Polonia 23
ES - Italia 18
AR - Argentina 16
MX - Messico 16
JP - Giappone 15
SE - Svezia 15
TR - Turchia 10
ZA - Sudafrica 10
LT - Lituania 9
AU - Australia 8
ID - Indonesia 7
IQ - Iraq 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
SA - Arabia Saudita 6
VE - Venezuela 6
BE - Belgio 5
TN - Tunisia 5
UA - Ucraina 5
MY - Malesia 4
NP - Nepal 4
PH - Filippine 4
UZ - Uzbekistan 4
BO - Bolivia 3
EC - Ecuador 3
GH - Ghana 3
IL - Israele 3
KE - Kenya 3
MA - Marocco 3
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
GT - Guatemala 2
HN - Honduras 2
OM - Oman 2
PY - Paraguay 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GA - Gabon 1
GD - Grenada 1
HR - Croazia 1
HT - Haiti 1
IE - Irlanda 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MW - Malawi 1
NI - Nicaragua 1
NR - Nauru 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.451
Città #
Singapore 333
Dallas 230
Moscow 175
Ashburn 147
Hong Kong 147
San Jose 126
Beijing 69
Shanghai 52
Hefei 50
Los Angeles 50
Milan 46
Lauterbourg 42
Ho Chi Minh City 36
New York 34
Orem 29
Nardò 28
Tito 28
Council Bluffs 27
Nuremberg 23
Rome 23
Hanoi 21
Santa Clara 21
São Paulo 17
Taranto 16
Chennai 15
North Bergen 15
London 13
Munich 13
Atlanta 12
Florence 12
Warsaw 12
Guangzhou 11
Mexico City 11
Stockholm 11
Tokyo 11
Turin 11
Boardman 10
Houston 10
Montreal 10
Toronto 10
Amsterdam 9
Bari 9
Falkenstein 9
Helsinki 9
Phoenix 9
Boston 8
Cascina 8
Frankfurt am Main 8
Johannesburg 8
Pietragalla 8
Sydney 8
Vienna 8
Denver 7
Haiphong 7
Poplar 7
Seattle 7
Tianjin 7
Turku 7
Ankara 6
Belo Horizonte 6
Bologna 6
Lappeenranta 6
Secaucus 6
Campinas 5
Clifton 5
Da Nang 5
Hangzhou 5
Naples 5
Piscataway 5
Rio de Janeiro 5
San Francisco 5
Shenzhen 5
Bexley 4
Brooklyn 4
Catania 4
Chicago 4
City of London 4
Curitiba 4
Ha Long 4
Mumbai 4
Newark 4
Nocera Inferiore 4
Palermo 4
Riyadh 4
Salvador 4
Tashkent 4
Washington 4
Wolfhagen 4
Wroclaw 4
Accra 3
Brasília 3
Brussels 3
Buffalo 3
Cagliari 3
Catanzaro 3
Changsha 3
Forlì 3
Fortaleza 3
Foshan 3
Francavilla al Mare 3
Totale 2.276
Nome #
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 294
The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer’s disease 163
Comparing two picture naming tasks in primary progressive aphasia: Insights from behavioural and neural results 160
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 130
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer's Disease continuum? 104
Gender Differences in Obstructive Sleep Apnea: A Preliminary Clinical and Polysomnographic Investigation 104
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 102
Dysphagia in primary progressive aphasia: Clinical predictors and neuroanatomical basis 100
Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia 98
Usefulness of the adult concentration inventory in the psychological assessment of adult sleep disorder patients 96
The dual effect of cholesterol on cognitive functions in REM sleep behavior disorder: A pilot study 94
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11-year follow-up study 94
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements 93
A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet 88
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns 87
Rheumatoid meningitis: a challenging diagnosis for neurologists 87
Early functional MRI changes in a prodromal semantic variant of primary progressive aphasia: a longitudinal case report 87
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 84
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment 83
Heterogeneity and overlap in the continuum of linguistic profile of logopenic and semantic variants of primary progressive aphasia: a Profile Analysis based on Multidimensional Scaling study 83
CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients 82
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 81
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 79
Early-phase fluid diagnostic biomarkers in acute ischemic stroke: a hybrid umbrella review 79
Cerebrospinal fluid biomarkers for dementia: A case of post-lumbar puncture epidural hematoma 78
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 77
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 77
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 77
Acute Symptomatic Sinus Bradycardia in High-Dose Methylprednisolone Therapy in a Woman With Inflammatory Myelitis: A Case Report and Review of the Literature 73
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 73
Depressive Symptoms Moderate the Association Between Functional Level at Admission to Intensive Post-Stroke Rehabilitation and Effectiveness of the Intervention 73
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 72
A case of hemichorea/hemiballismus in a patient with Alzheimer’s disease and history of Sydenham’s chorea: the return of an old acquaintance? 72
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 71
Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia 69
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 68
Primary progressive aphasia: six questions in search of an answer 65
Data-driven subtypes of subjective cognitive decline: neuropsychological profiles, Alzheimer’s disease biomarkers, and clinical trajectories 63
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 63
Expanding the Framework on Multimodal Biomarkers in iRBD. Response to Carpi et al 62
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 61
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 59
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 58
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study 54
The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study 54
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol 54
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross‐sectional and longitudinal study 53
KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment 53
Tracking prodromal α-synucleinopathies: novel fluid- and tissue-based biomarker approaches for iRBD phenoconversion 52
Per2 C111G polymorphism influences cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. A 10-year follow-up study 51
Intermediate alleles of HTT: A new pathway in longevity 50
From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study 49
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 47
Personalized modeling of Alzheimer's disease progression estimates neurodegeneration severity from EEG recordings 44
Mutational Landscape of Alzheimer’s Disease and Frontotemporal Dementia: Regional Variances in Northern, Central, and Southern Italy 44
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 42
Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment 41
Dural arteriovenous fistula presenting as temporal venous engorgement 23
Early stages of cognitive decline are characterized by different EEG microstates dynamics 8
P300 event-related potential in patients with cognitive decline correlates with task performance 8
A machine learning model to predict progression from subjective cognitive decline to mild cognitive impairment and dementia: a 12‐year follow‐up study 7
The Role of Background Activity Monitoring by Amplitude-Integrated EEG to Predict Short-Term Neurological Outcome in Neonates with Congenital Heart Disease: Insights from a Real-Life Retrospective Cohort 4
Plasma neurofilament light chain predicts Alzheimer’s disease in patients with subjective cognitive decline and mild cognitive impairment: a longitudinal study 3
Staging Language‐Led Neurodegenerative Diseases in a Language‐Based World: The Challenge of the PPA-Squared Scale 1
Rethinking Alzheimer's disease susceptibility and heterogeneity. Comment on Miller et al 1
Totale 4.606
Categoria #
all - tutte 16.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221 0 0 0 1 0 0 0 0 0 0 0 0
2022/20236 2 1 0 0 1 1 0 1 0 0 0 0
2023/2024109 0 0 2 0 0 5 0 87 6 1 5 3
2024/2025820 47 15 1 122 87 55 158 75 99 52 39 70
2025/20263.668 186 199 285 441 331 121 318 294 912 217 193 171
Totale 4.606